#biotech
articles
Health
Former Pfizer R&D Chief Mikael Dolsten Joins Quantumcell Board
The ex-Pfizer research head joins the Danish biotech as the $12 million upfront payment for Alzecure's Alzheimer platfor...
Markets
Biotech investing: chasing the thrill of clinical success amid extraordinary risk
Biotechnology stocks have become a standalone investment theme, blending breakthrough science with extreme volatility. H...
Companies
arGEN-X to Acquire Forte Biosciences in $2.2 Billion Immunology Pipeline Deal
Dutch biotech arGEN-X is buying US-based Forte Biosciences for $2.2 billion, adding a promising anti-CD122 antibody for ...
Education
Nobel Laureate Fred Ramsdell Says Biotech, Not Universities, Drives Breakthrough Medical Science
Immunologist Fred Ramsdell argues that biotech’s team-oriented mission beats university labs’ fragmented incentive struc...